NCT01819857View on ClinicalTrials.gov

Droperidol and Cardiac Repolarization

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Cardiac Repolarization
Interventions
DRUG

Xomolix 0.625 mg intravenously

intravenous administration of 0.625 mg droperidol

DRUG

Xomolix 1.25 mg

intravenous administration of 1.25 mg droperidol

DRUG

Zofran 8 mg

intravenous administration of 8 mg ondansetron

Trial Locations (1)

80-214

Medical University of Gdansk, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT01819857 - Droperidol and Cardiac Repolarization | Biotech Hunter | Biotech Hunter